Amanda Willig, PhD, RD

Assistant Professor
University of Alabama at Birmingham
Birmingham, AL

Disclosure: Nothing to disclose

Presentation(s):

• LB9 - The Effect of Initiating Integrase Inhibitor-based vs. Non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care

  Friday, October 4
  1:55 PM – 2:05 PM